Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05374616 · ClinicalTrials.gov registry record
Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
A clinical trial of TANGO2-related Disorder, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05374616: Recruiting study of TANGO2-related Disorder, sponsored by Baylor College of Medicine.
NCT05374616 is a study of TANGO2-related Disorder that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05374616, a study of TANGO2-related Disorder, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to establish a biorepository of individuals with TANGO2 deficiency to support scientific research and establish a comprehensive clinical database of affected individuals to understand the disease course.
Primary Outcome
Detailed interview with participants and review of medical records will be used to assess the frequency and triggers of metabolic and cardiac crises
Conditions Studied
Interventions
- GENETIC Observation
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2030-01-01 |
What NCT05374616 shows while recruiting
NCT05374616 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with TANGO2-related Disorder appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT05374616 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05374616 about?
NCT05374616 is a clinical study titled "Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder". The study aims to establish a biorepository of individuals with TANGO2 deficiency to support scientific research and establish a comprehensive clinical database of affected individuals to understand the disease course.
What is the current status of trial NCT05374616?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2018-05-18. Estimated completion is 2030-01-01.
What conditions does trial NCT05374616 study?
This clinical trial studies the following conditions: TANGO2-related Disorder.
What interventions are being tested in trial NCT05374616?
The interventions under investigation include: Observation (GENETIC).
Who is sponsoring clinical trial NCT05374616?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05374616 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI